Screener
Mesa Laboratories MLAB Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Mesa Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Mesa Laboratories’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026808
FAQ
- What is Mesa Laboratories's cash & equivalents?
- Mesa Laboratories (MLAB) reported cash & equivalents of $30.7M in Q2 2026.
- How has Mesa Laboratories's cash & equivalents changed year-over-year?
- Mesa Laboratories's cash & equivalents increased by 44.3% year-over-year, from $21.28M to $30.7M.
- What is the long-term trend for Mesa Laboratories's cash & equivalents?
- Over 3 years (2021 to 2026), Mesa Laboratories's cash & equivalents has grown at a -53.3% compound annual growth rate (CAGR), from $263.87M to $26.93M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Mesa Laboratories's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude